Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.

Joseph F. Gordon net worth and biography

Joseph Gordon Biography and Net Worth

Insider of Bausch Health Companies

Joseph F. Gordon is President & Co-Head Bausch + Lomb/International of the company since August 2018. He previously served as our President, Consumer and Vision Care from December 2016 through July 2018 and as General Manager of U.S. Consumer from August 2013 to November 2016. Prior to joining Bausch Health in 2013, Mr. Gordon served in various positions with Bausch + Lomb, where he most recently served as Vice President, Sales and Marketing, Global Consumer from January 2011 to July 2013. Earlier in his career, he led sales and marketing organizations within Pfizer Inc., and Wyeth, a pharmaceutical company purchased by Pfizer Inc. in 2009.

How do I contact Joseph F. Gordon?: The corporate mailing address for Mr. Gordon and other Bausch Health Companies executives is 2150 ST. ELZEAR BLVD. WEST, LAVAL A8, H7L 4A8. Bausch Health Companies can also be reached via phone at (514) 744-6792 and via email at [email protected]. Learn More on Joseph F. Gordon's contact information.
Has Joseph F. Gordon been buying or selling shares of Bausch Health Companies?: Joseph F. Gordon has not been actively trading shares of Bausch Health Companies during the past quarter. Most recently, Joseph F. Gordon sold 3,889 shares of the business's stock in a transaction on Tuesday, March 8th. The shares were sold at an average price of $21.76, for a transaction totalling $84,624.64. Learn More on Joseph F. Gordon's trading history.
Who are Bausch Health Companies' active insiders?: Bausch Health Companies' insider roster includes Christina Ackermann (EVP), Seana Carson (EVP), Richard DeSchutter (Director), Sam Eldessouky (CFO), Joseph Gordon (Insider), William Humphries (Insider), Steven Miller (Director), Robert Spurr (Insider), and Amy Wechsler (Director). Learn More on Bausch Health Companies' active insiders.
Are insiders buying or selling shares of Bausch Health Companies?: In the last year, insiders at the sold shares 1 times. They sold a total of 13,370 shares worth more than $83,027.70. The most recent insider tranaction occured on September, 6th when EVP Seana Carson sold 13,370 shares worth more than $83,027.70. Insiders at Bausch Health Companies own 8.1% of the company. Learn More about insider trades at Bausch Health Companies.
Information on this page was last updated on 9/6/2024.

Joseph F. Gordon Insider Trading History at Bausch Health Companies

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/8/2022	Sell	3,889	$21.76	$84,624.64
3/1/2022	Sell	6,338	$23.82	$150,971.16

Joseph F. Gordon Buying and Selling Activity at Bausch Health Companies

Bausch Health Companies Company Overview

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Today's Range

Now: $7.77

$7.65

$7.79

50 Day Range

MA: $8.37

$7.59

$9.78

2 Week Range

Now: $7.77

$3.96

$11.46

Volume

662,688 shs

Average Volume

2,759,066 shs

Market Capitalization

$2.81 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.69

First JFK… next Elon?

From Porter & Company | Ad